SCHEMBL8306736

SCHEMBL8306736

CC(=NO)c1cnc(CCOC2CCCCO2)c(-c2ccccc2)c1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.48
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ADORA3 P0DMS8 1/20 0.38
CNR1 P21554 1/20 0.35
CREBBP Q92793 2/20 0.33
EP300 Q09472 1/20 0.33
MET P08581 2/20 0.33
AVPR2 P30518 1/20 0.32
OXTR P30559 1/20 0.32
AVPR1A P37288 1/20 0.32
AVPR1B P47901 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8309114 0.82 KDM4C (0.50) KDM4CNPC1RAB9AL3MBTL1MEN1
SCHEMBL6933743 0.82 KDM4C (0.43) KDM4CNPC1RAB9AL3MBTL1MEN1
SCHEMBL8309642 0.78 KDM4C (0.42) KDM4CNPC1RAB9AL3MBTL1MEN1
SCHEMBL8305338 0.73 KDM4C (0.41) KDM4CNPC1RAB9AL3MBTL1MEN1
SCHEMBL6933894 0.73 KDM4C (0.44) KDM4CNPC1RAB9AL3MBTL1MEN1
SCHEMBL8308833 0.72 PPARG (0.48) KDM4CNPC1RAB9AL3MBTL1MEN1
SCHEMBL8305972 0.71 KDM4C (0.42) KDM4CNPC1RAB9AL3MBTL1ADORA3
SCHEMBL8307747 0.69 MEN1 (0.39) KDM4CNPC1RAB9AL3MBTL1MEN1
SCHEMBL8309988 0.69 KDM4C (0.43) KDM4CNPC1RAB9AL3MBTL1MEN1
SCHEMBL8304159 0.69 KDM4C (0.41) KDM4CNPC1RAB9AL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed